NeuroSense Therapeutics Ltd (NRSN) - Kapitalizatsiyaning foydaga nisbati
NeuroSense Therapeutics (NRSN) kompaniyasining -2.20 indikatori bilan ko'rsatilgan ushbu kunlik narxlar grafigi ALS terapiyasini ishlab chiqayotgan va PrimeC uchun kamyob dori vositasi maqomini izlayotgan biotexnologiya firmasining trayektoriyasini aks ettiradi. Biznes dumpingga qarshi patent himoyasiga tayanadi, bunda muvaffaqiyat klinik sinovlarning samaradorligiga bog'liq. Isroilda tashkil etilgani va mintaqaviy xatarlarga qaramay, kompaniyaning gumanitar profili uning intellektual mulkini himoya qiladi.
NeuroSense Therapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati NeuroSense Therapeutics|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti NeuroSense Therapeutics, Ltd.|NRSN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar NeuroSense Therapeutics Ltd.|NRSN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi NeuroSense Therapeutics|Oraliq qoplama koeffitsiyenti neurosense-tx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
NRSN - Sof foyda|Kutilayotgan sof foyda NeuroSense Therapeutics|NRSN - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori NeuroSense Therapeutics, Ltd.|NRSN - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti NeuroSense Therapeutics Ltd.|NRSN - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda NeuroSense Therapeutics|NRSN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi neurosense-tx.com|NRSN - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi NeuroSense Therapeutics
Kompaniyaning jamlanma tahlili:NRSN (neurosense-tx.com)
P/E koeffitsiyenti aksiyaning bozor qiymatini bir aksiyaga to'g'ri keladigan sof foyda bilan bog'laydi va joriy daromad darajalari asosida investitsiyalarning qoplash muddatini belgilaydi. Innovatsion ALS terapiyasini ishlab chiqayotgan NeuroSense Therapeutics (NRSN) uchun ushbu ko'rsatkich bozorning kelajakdagi yutuqlarga bo'lgan kutganlarini aks ettiradi, bu esa kompaniyaning oylik P/E dinamikasida spekulyativ salohiyat va fundamental risklar prizmasi orqali yaqqol namoyon bo'ladi.
Raqobatdosh kompaniyalar tahlili
Narx-foyda multiplikatori BIIB (biogen.com)|P/E multiplikatori NBIX|RGC - Kapitalizatsiyaning foydaga nisbati|Axsome Therapeutics Inc - Narx-foyda koeffitsiyenti|P/E multiplikatori ACADIA Corp ACAD|XENE - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati VKTX (vikingtherapeutics.com)|Supernus (SUPN) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Catalyst Pharma (CPRX)|Narxning foydaga nisbati Denali Therapeutics Inc|Harmony Corp (HRMY) - Biznesning o‘zini qoplash muddati|P/E multiplikatori BHVN|AMLX - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX: Narx-foyda multiplikatori|AVXL - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati CeriBell EEG CBLL|PRTA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alector (ALEC)|Narx-foyda koeffitsiyenti ANNX|OMER: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti NGNE (Neurogene Corp)|Bozor narxining sof foydaga nisbati ACIU|P/E multiplikatori VYGR (Voyager Therapeutics)|Kompaniya qiymatining sof foydaga nisbati NMRA|Scilex - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Holdings Inc.|alphacognition.com (ACOG) - Narxning foydaga nisbati|Cognition Therapeutics Inc. - Kompaniya qiymatining sof foydaga nisbati|IKT (Inhibikase Therapeutics) - P/E multiplikatori|P/E multiplikatori cassavasciences.com|Narxning foydaga nisbati Assertio Holdings, Inc. (ASRT)|COYA: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalizatsiyaning foydaga nisbati|ABOS: Narx-foyda koeffitsiyenti|CRVO - P/E multiplikatori|ATHE (alteritytherapeutics.com) - Narx-foyda koeffitsiyenti|CLNN: Bozor narxining sof foydaga nisbati|PEPG (PepGen Inc) - P/E multiplikatori|Jupiter Neurosciences, Inc. (JUNS) - Biznesning o‘zini qoplash muddati|P/E multiplikatori RLMD|Narx-foyda koeffitsiyenti annovisbio.com ANVS|Narxning foydaga nisbati Grace Therapeutics GRCE|Biznesning o‘zini qoplash muddati Firefly Neuroscience, Inc. (AIFF)|KLTO - Narxning foydaga nisbati|RVPH (Reviva Pharmaceuticals, Inc.) - Narx-foyda multiplikatori|metaviatx.com (MTVA) - Narxning foydaga nisbati|neuraxis.com - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Helius Medical Technologies, Inc.|Passage Bio Corp (PASG) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Neuphoria Therapeutics Inc. (NEUP)|Minerva - Narx-foyda multiplikatori|Narxning foydaga nisbati Athira Pharma, Inc. ATHA|ADXN: Narx-foyda multiplikatori|Alzamend - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Cyclerion Therapeutics|PTIX (protagenic.com) - Narx-foyda koeffitsiyenti|Pasithea Therapeutics Corp. (KTTA) - P/E multiplikatori|Narxning foydaga nisbati Cortigent Inc|ATXI: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|CARA - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|ELYM: Narx-foyda multiplikatori|Intra-Cellular - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati longboardpharma.com|MRNS (Marinus Pharmaceuticals, Inc.) - Narx-foyda koeffitsiyenti|NKGen Biotech Inc (NKGN) - P/E multiplikatori|Narxning foydaga nisbati NeuroBo|SAGE: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Synaptogenix, Inc. (SNPX)|TRVN - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Biznesning o‘zini qoplash muddati anewmeds.com (WENA)|Cerevel - P/E multiplikatori
